News

The project utilizes a proprietary antigen design technology developed by Algonomics and will be funded by IAVI’s Innovation Fund, a funding mechanism that seeks out novel and typically

Prior to the Dow appointment, she served as director of Research and Development for Biocor Animal Health (Biocor) where she was responsible for all aspects of design and

To conserve capital resources, Altus will discontinue its Trizytek program activities and focus on the advancement of the company’s breakthrough, long-acting, recombinant human growth hormone candidate, ALTU-238, as

The license expands Artemis’s clinical and research program and will allow the company to develop a non-invasive prenatal blood test that accurately predicts chromosomal and genetic disorders. This

According to the company, the GelVac nasal powder platform brings distinct benefits to the vaccine products and patients. It is preservative-free, adjuvant-free and can stabilize vaccines at room

The Carpentier-Edwards Physio II ring is a novel mitral valve repair solution. It is the only annuloplasty ring offering ‘shape optimization’, which matches the geometry of the ring

Sirion Therapeutics is seeking approval for ganciclovir as a treatment for herpetic keratitis, an ocular disease caused by the herpes simplex virus. The FDA has issued an action

The company has reduced its headcount by 17 since June 2008, from 42 to 25, including the closure of its therapeutics business in Boston. This is the end

Investors will also receive warrants to purchase 14.22 million shares of Avi BioPharma common stock. The closing of the offering is expected to take place on January 30,